Statins May Prevent Dementia in People with High Genetic Risk
New research reveals statins could reduce dementia risk by 85% in genetically susceptible individuals, offering personalized prevention.
Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
126 Artikel
New research reveals statins could reduce dementia risk by 85% in genetically susceptible individuals, offering personalized prevention.
Case study shows how methylmalonic acidemia disrupts dopamine pathways, causing severe movement disorders in adults.
Scientists identify specific brain neurons that control withdrawal symptoms, opening new therapeutic pathways.
Andrew Huberman shares science-backed strategies to optimize dopamine for sustained motivation and enhanced cognitive performance.
Neuroscientist Dr. Read Montague reveals how brain chemicals shape learning, motivation, and the hidden costs of instant gratification.
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
New research reveals how tiny plastic particles we consume daily could damage brain cells through five key biological pathways.
UCLA research links chlorpyrifos pesticide exposure to 2.5x higher Parkinson's risk by damaging brain's protein cleanup system.
New research reveals ADHD brains slip into brief sleep-like episodes during waking hours, explaining attention lapses and slower reactions.
New research reveals depression often appears years before Parkinson's or dementia diagnosis, suggesting it reflects early brain changes.
Major study identifies three existing drugs that could be repurposed to fight Alzheimer's disease, offering faster path to treatment.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.